BiotechTube
Home/Imbria Pharmaceuticals/Albert M. Kim, MD, PhD
AM

Albert M. Kim, MD, PhD

Chief Medical Officer

Imbria Pharmaceuticals

Therapeutic Areas

CardiovascularMetabolic Diseases

Imbria Pharmaceuticals Pipeline

DrugIndicationPhase
NinerafaxstatNon-obstructive Hypertrophic Cardiomyopathy (nHCM)Phase 2b

Leadership Team at Imbria Pharmaceuticals

AS
Alvin Shih, MD
Chief Executive Officer
View full Imbria Pharmaceuticals profile